It all started pleasantly enough.
Katten Muchin Rosenman announced it had hired partner Deepro Mukerjee and eventually four other patent attorneys from Alston & Bird in April. The firm told the New York Law Journal the new team was expected “to generate significant revenue for the firm in the pharmaceutical space.”
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]